Outcomes of the first-in-human study with a recombinant botulinum toxin type E (rBoNT-E): Safety and pharmacodynamic profile of rBoNT-E compared with abobotulinumtoxinA (Dysport®)

Saved in:
Bibliographic Details
Published in:Toxicon (Oxford) 2018-12, Vol.156, p.S93-S93
Main Authors: Pons, Laurent, Vilain, Claire, Picaut, Philippe
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0041-0101
1879-3150
DOI:10.1016/j.toxicon.2018.11.224